Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 5
2008 1
2009 6
2010 4
2011 1
2012 1
2013 4
2014 4
2015 3
2016 3
2017 5
2018 6
2019 2
2020 2
2021 6
2022 4
2023 4
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Juvenile dermatomyositis. Where are we now?
McCann LJ, Livermore P, Wilkinson MGL, Wedderburn LR. McCann LJ, et al. Clin Exp Rheumatol. 2022 Feb;40(2):394-403. doi: 10.55563/clinexprheumatol/56ilob. Epub 2022 Feb 7. Clin Exp Rheumatol. 2022. PMID: 35225221 Free article. Review.
Consensus-based recommendations for the management of juvenile dermatomyositis.
Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, van der Net J, Vastert S, Wedderburn LR, Wulffraat N, McCann LJ, van Royen-Kerkhof A. Bellutti Enders F, et al. Among authors: mccann lj. Ann Rheum Dis. 2017 Feb;76(2):329-340. doi: 10.1136/annrheumdis-2016-209247. Epub 2016 Aug 11. Ann Rheum Dis. 2017. PMID: 27515057 Free PMC article. Review.
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
Brunner HI, Abud-Mendoza C, Viola DO, Calvo Penades I, Levy D, Anton J, Calderon JE, Chasnyk VG, Ferrandiz MA, Keltsev V, Paz Gastanaga ME, Shishov M, Boteanu AL, Henrickson M, Bass D, Clark K, Hammer A, Ji BN, Nino A, Roth DA, Struemper H, Wang ML, Martini A, Lovell D, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). Brunner HI, et al. Ann Rheum Dis. 2020 Oct;79(10):1340-1348. doi: 10.1136/annrheumdis-2020-217101. Epub 2020 Jul 22. Ann Rheum Dis. 2020. PMID: 32699034 Free PMC article. Clinical Trial.
Juvenile dermatomyositis: Latest advances.
Wu Q, Wedderburn LR, McCann LJ. Wu Q, et al. Among authors: mccann lj. Best Pract Res Clin Rheumatol. 2017 Aug;31(4):535-557. doi: 10.1016/j.berh.2017.12.003. Epub 2018 Jan 10. Best Pract Res Clin Rheumatol. 2017. PMID: 29773272 Review.
Considerations in Charcot Reconstruction.
McCann LJ, Dickinson JD. McCann LJ, et al. Clin Podiatr Med Surg. 2024 Jan;41(1):141-151. doi: 10.1016/j.cpm.2023.06.005. Epub 2023 Jul 18. Clin Podiatr Med Surg. 2024. PMID: 37951671 Review.
The Vasculopathy of Juvenile Dermatomyositis.
Papadopoulou C, McCann LJ. Papadopoulou C, et al. Among authors: mccann lj. Front Pediatr. 2018 Oct 9;6:284. doi: 10.3389/fped.2018.00284. eCollection 2018. Front Pediatr. 2018. PMID: 30356795 Free PMC article. Review.
Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis.
Saketkoo LA, Valenzuela A, Kim S, McCann LJ, Lood C, Wahezi DM, Werth VP, Yi B, Alexanderson H, Maillard S, Pilkington C, Fligelstone K, Limbach B, Orandi AB, Regardt M, Russell AM, Davuluri S, deGroot I, Ernste F, Paik JJ, von Muhlen CA, Dimachkie MM, Machado PM, Naddaf E, Shafranski BM, Gupta L, Zulian F, Chung L; International Myositis Assessment and Clinical Studies Group and The Myositis International Research and Health Collaborative Alliance (IMACS/MIHRA) Calcinosis Scientific Interest Group. Saketkoo LA, et al. Among authors: mccann lj. Rheumatology (Oxford). 2024 May 2;63(5):1189-1191. doi: 10.1093/rheumatology/kead331. Rheumatology (Oxford). 2024. PMID: 37449887 No abstract available.
54 results